BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7021831)

  • 1. Structure-activity relationships in dihydropteroate synthase inhibition by sulfanilamides. Comparison with the antibacterial activity.
    De Benedetti PG; Rastelli A; Frassineti C; Cennamo C
    J Med Chem; 1981 Apr; 24(4):454-7. PubMed ID: 7021831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative structure-activity analysis in dihydropteroate synthase inhibition by sulfones. Comparison with sulfanilamides.
    De Benedetti PG; Iarossi D; Menziani C; Caiolfa V; Frassineti C; Cennamo C
    J Med Chem; 1987 Mar; 30(3):459-64. PubMed ID: 3546688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mafenide on dihydropteroate synthase.
    Eagon RG; McManus AT
    J Antimicrob Chemother; 1990 Jan; 25(1):25-9. PubMed ID: 2108114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphanilic acid inhibits dihydropteroate synthase.
    Eagon RG; McManus AT
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1936-8. PubMed ID: 2514624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid-mediated sulfanilamide resistance.
    Nagate T; Inoue M; Inoue K; Mitsuhashi S
    Microbiol Immunol; 1978; 22(7):367-75. PubMed ID: 713872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-activity relationships in dihydropteroate synthase inhibition by multisubstituted sulfones. Design and synthesis of some new derivatives with improved potency.
    De Benedetti PG; Iarossi D; Folli U; Frassineti C; Menziani MC; Cennamo C
    J Med Chem; 1989 Oct; 32(10):2396-9. PubMed ID: 2677378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of omega-(4-aminophenylsulfonamido)alkyl disulfides and thiosulfates and their activity against dihydropteroate synthetase from sulfanilamide-resistant Neisseria gonorrhoeae.
    Foye WO; Kauffman JM; Suttimool W
    J Pharm Sci; 1982 Jul; 71(7):799-802. PubMed ID: 6811724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic aspects of the antibacterial action of sulfanilamides.
    De Benedetti PG; Rastelli A; Melegari M; Albasini A
    J Med Chem; 1978 Dec; 21(12):1325-7. PubMed ID: 722744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines.
    Lever OW; Bell LN; McGuire HM; Ferone R
    J Med Chem; 1985 Dec; 28(12):1870-4. PubMed ID: 3906132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of dihydropteroate synthase: substituent effects in the side-chain aromatic ring of 6-[[3-(aryloxy)propyl]amino]-5-nitrosoisocytosines and synthesis and inhibitory potency of bridged 5-nitrosoisocytosine-p-aminobenzoic acid analogues.
    Lever OW; Bell LN; Hyman C; McGuire HM; Ferone R
    J Med Chem; 1986 May; 29(5):665-70. PubMed ID: 3486292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.
    Capasso C; Supuran CT
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):379-87. PubMed ID: 23627736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative QSAR analysis in dihydropteroate synthase inhibition by sulphones. Design and synthesis of some new derivatives with improved potency.
    De Benedetti PG; Iarossi D; Frassineti C; Menziani MC; Cocchi M; Cennamo C
    Prog Clin Biol Res; 1989; 291():345-8. PubMed ID: 2726870
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-activity of sulfones and sulfonamides on dihydropteroate synthetase from Neisseria meingitidis.
    Ho RI; Corman L; Mores SA; Schneider H
    Antimicrob Agents Chemother; 1975 Jun; 7(6):758-63. PubMed ID: 808157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of different plasmid-borne dihydropteroate synthases mediating bacterial resistance to sulfonamides.
    Swedberg G; Sköld O
    J Bacteriol; 1980 Apr; 142(1):1-7. PubMed ID: 6989796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs.
    Merali S; Zhang Y; Sloan D; Meshnick S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1075-8. PubMed ID: 2203302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of sulfa drugs against recombinant Pneumocystis carinii dihydropteroate synthetase and in vivo.
    Hong YL; Hossler P; Bartlett M; Queener S; Smith J; Meshnick S
    J Eukaryot Microbiol; 1996; 43(5):40S. PubMed ID: 8822843
    [No Abstract]   [Full Text] [Related]  

  • 17. Portage transport of sulfanilamide and sulfanilic acid.
    Hwang SY; Berges DA; Taggart JJ; Gilvarg C
    J Med Chem; 1989 Mar; 32(3):694-8. PubMed ID: 2645404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
    Allegra CJ; Boarman D; Kovacs JA; Morrison P; Beaver J; Chabner BA; Masur H
    J Clin Invest; 1990 Feb; 85(2):371-9. PubMed ID: 2298911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R-factor-mediated resistance to sulfonamides by a plasmid-borne, drug-resistant dihydropteroate synthase.
    Sköld O
    Antimicrob Agents Chemother; 1976 Jan; 9(1):49-54. PubMed ID: 769673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-Aminobenzoic acid derivatives as inhibitors of the cell-free H2-pteroate synthesizing system of Escherichia coli.
    Thijssen HH
    J Med Chem; 1977 Feb; 20(2):233-6. PubMed ID: 319235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.